Erina Paul

Merck & Co., Inc.

1 appearance in the program

Sessions & presentations

Presentation: Application of Bayesian approach for immunogenicity assessment in early phase vaccine studies

Contributed Papers · Tue, Aug 4 , 2:00 PM

Co-Author

↑